V. Visconti

Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.

C. Lau, S. M. Kazmi, R. Plante, 1996, Cancer research.

Purification, characterization, and structural elucidation of the active moiety of the previously called "suppressor activating factor (SAF)".

C. Lau, A. Ishaque, V. Visconti, 1990, Cellular immunology.

Suppression of NFκB activation and NFκB‐dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5‐lipoxygenase

Lubing Zhou, C. Lau, S. M. Kazmi, 1995 .

Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase.

L. Zhou, C. Lau, S. M. Kazmi, 1995, Journal of cellular biochemistry.

Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model.

E. Chourmouzis, C. Lau, D. Li, 1990, Bone marrow transplantation.

Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line.

C. Lau, A. Ishaque, D. Li, 1985, Journal of immunology.

Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation.

C. Lau, S. M. Kazmi, A. Ishaque, 1993, Endocrinology.